In his blue suit, white shirt, and red tie, Trump cemented his commitment to government-funded in-vitro fertilization (IVF) access to American voters. Once in office, Trump’s promise of IVF access would be put to the test. Instead of IVF, Christian religious groups propose treating the “root causes” of infertility by tracking patients’ menstrual cycles to help expose underlying conditions such as endometriosis. Trump’s plan to increase IVF access involves a deal with EMD Serono, the largest manufacturer of IVF drugs globally, and a subsidiary of Germany’s Merck, a major pharmaceutical manufacturer. The new IVF policy also stops short of mandating taxpayer-subsidized coverage after an intense lobbying campaign by pro-life advocates, bringing the viability of government funding into question.